Dolobid and Injection site pruritus - a phase IV clinical study of FDA data
No or few reports are found.
The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
No or few reports are found.
What is Dolobid?
Dolobid has active ingredients of diflunisal. Currently, eHealthMe is studying from 350 Dolobid users.
What is Injection Site Pruritus?
Injection site pruritus (severe itching at injection site) is found to be associated with 1,811 drugs and 1,063 conditions by eHealthMe. Currently, we are studying 59,484 people who have Injection site pruritus.
Do you take Dolobid and have Injection site pruritus?Check whether Injection site pruritus is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Dolobid side effects by duration, gender and age:
- Dolobid side effects (350 reports)
Injection site pruritus treatments and more:
- Injection site pruritus (59,484 reports)
All the drugs that are associated with Injection site pruritus:
All the conditions that are associated with Injection site pruritus:
How the study uses the data?
The study uses data from the FDA. It is based on diflunisal (the active ingredients of Dolobid) and Dolobid (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Oxycontin and Gingival Bleeding - 6 seconds ago
- Hydroxyzine and Synovitis - 8 seconds ago
- Nizoral A-D and Mirapex drug interaction - 17 seconds ago
- Thiamine Hydrochloride and Hypertonic Bladder - 26 seconds ago
- Lexapro and Drug Ineffective - 28 seconds ago
- Clofarabine and Losartan Potassium drug interaction - 30 seconds ago
- Loperamide Hydrochloride and Liothyronine Sodium drug interaction - 31 seconds ago
- Raspberry Ketone and Adderall drug interaction - 38 seconds ago
- Mucomyst and Sinus Disorder - 39 seconds ago
- Flutamide and Malaise - 39 seconds ago